Effects of a psychosocial intervention at one-year follow-up in a PREDIMED-plus sample with obesity and metabolic syndrome.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 04 2021
Historique:
received: 20 11 2020
accepted: 08 04 2021
entrez: 29 4 2021
pubmed: 30 4 2021
medline: 21 10 2021
Statut: epublish

Résumé

This study examines if overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms, and if these variables could be modified after 1 year of a multimodal intervention (diet, physical activity, psychosocial support). 342 adults (55-75 years) with overweight/obesity and metabolic syndrome (MetS) from the PREDIMED-Plus Cognition study were randomized to the intervention or to the control group (lifestyle recommendations). Cognitive and psychopathological assessments were performed at baseline and after 1-year follow-up. At baseline, higher impulsivity was linked to higher food addiction and depressive symptoms, but not to body mass index (BMI). Food addiction not only predicted higher BMI and depressive symptoms, but also achieved a mediational role between impulsivity and BMI/depressive symptoms. After 1 year, patients in both groups reported significant decreases in BMI, food addiction and impulsivity. BMI reduction and impulsivity improvements were higher in the intervention group. Higher BMI decrease was achieved in individuals with lower impulsivity. Higher scores in food addiction were also related to greater post-treatment impulsivity. To conclude, overweight/obesity are related to higher impulsivity, food addiction and depressive symptoms in mid/old age individuals with MetS. Our results also highlight the modifiable nature of the studied variables and the interest of promoting multimodal interventions within this population.

Identifiants

pubmed: 33911087
doi: 10.1038/s41598-021-88298-1
pii: 10.1038/s41598-021-88298-1
pmc: PMC8080657
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9144

Références

Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
J Sci Food Agric. 2020 May;100(7):2946-2952
pubmed: 32031258
Addict Behav. 2020 Dec;111:106533
pubmed: 32771795
Nutrients. 2016 Oct 28;8(11):
pubmed: 27801819
Front Psychol. 2016 Feb 02;7:61
pubmed: 26869963
J Behav Addict. 2014 Jun;3(2):128-32
pubmed: 25215224
Alcohol Clin Exp Res. 2013 Sep;37(9):1441-50
pubmed: 23578176
Obes Surg. 2002 Feb;12(1):14-8
pubmed: 11868290
Curr Obes Rep. 2015 Sep;4(3):303-10
pubmed: 26627487
Science. 2004 Oct 15;306(5695):457-61
pubmed: 15486293
Eat Weight Disord. 2006 Sep;11(3):126-32
pubmed: 17075239
J Health Psychol. 2008 Nov;13(8):1190-7
pubmed: 18987092
Eur Eat Disord Rev. 2017 Nov;25(6):601-606
pubmed: 29057603
Arch Gen Psychiatry. 2010 Mar;67(3):220-9
pubmed: 20194822
Am J Clin Nutr. 2009 May;89(5):1588S-1596S
pubmed: 19339401
Science. 1997 Feb 28;275(5304):1293-5
pubmed: 9036851
J Neurosci. 2011 Mar 23;31(12):4360-6
pubmed: 21430137
Psychol Med. 2016 Aug;46(11):2423-34
pubmed: 27299672
J Pers Assess. 2010 Jan;92(1):70-7
pubmed: 20013458
Front Psychiatry. 2018 May 25;9:208
pubmed: 29887808
Behav Pharmacol. 2012 Sep;23(5-6):609-15
pubmed: 22785438
Appetite. 2011 Dec;57(3):711-7
pubmed: 21907742
Int J Obes (Lond). 2010 Mar;34(3):407-19
pubmed: 19997072
Obes Rev. 2011 Aug;12(8):583-92
pubmed: 21535360
Psychol Bull. 2008 Nov;134(6):807-28
pubmed: 18954158
Endocr Rev. 2008 Dec;29(7):777-822
pubmed: 18971485
Psychopharmacology (Berl). 2016 Sep;233(18):3361-70
pubmed: 27449350
Dig Dis. 2008;26(1):36-9
pubmed: 18600013
PLoS One. 2016 Sep 30;11(9):e0163901
pubmed: 27690367
J Affect Disord. 2018 Jan 1;225:381-388
pubmed: 28846960
Int J Obes (Lond). 2008 Jun;32(6):881-91
pubmed: 18414420
Physiol Behav. 2018 Mar 15;186:25-30
pubmed: 29326031
J Dual Diagn. 2021 Jan-Mar;17(1):34-51
pubmed: 33404373
Compr Psychiatry. 2017 Apr;74:118-124
pubmed: 28160693
Eur Psychiatry. 2019 Sep;61:9-16
pubmed: 31255958
Circulation. 2006 Jan 31;113(4):499-506
pubmed: 16449729
Am J Clin Nutr. 1976 Aug;29(8):895-9
pubmed: 941870
Hum Brain Mapp. 2010 Jul;31(7):1052-64
pubmed: 19998366
JAMA. 2019 Oct 15;322(15):1486-1499
pubmed: 31613346
CNS Spectr. 2014 Aug;19(4):293-304
pubmed: 24103843
Prog Neurobiol. 2013 Sep;108:44-79
pubmed: 23856628
Neuroimage. 2005 Sep;27(3):669-76
pubmed: 15993629
Diabetes Care. 2019 May;42(5):777-788
pubmed: 30389673
Appetite. 2017 May 1;112:59-68
pubmed: 28087369
Diabetes Metab Syndr Obes. 2019 Dec 05;12:2567-2582
pubmed: 31827331
Patient Educ Couns. 2010 Jun;79(3):372-7
pubmed: 20399590
Psychol Med. 2015 Mar;45(4):771-82
pubmed: 25118940
Eat Behav. 2015 Dec;19:9-14
pubmed: 26164390
Brain. 2000 Nov;123 ( Pt 11):2189-202
pubmed: 11050020
PLoS One. 2013 Nov 20;8(11):e79143
pubmed: 24278117
Brain Cogn. 2018 Jun;123:103-109
pubmed: 29550505
Front Behav Neurosci. 2019 Jun 25;13:136
pubmed: 31293401
Psychol Addict Behav. 2016 Feb;30(1):113-21
pubmed: 26866783
Eat Weight Disord. 2006 Mar;11(1):e15-9
pubmed: 16801734
Appl Physiol Nutr Metab. 2007 Feb;32(1):76-88
pubmed: 17332786
J Neurosci. 2016 Jun 29;36(26):6949-56
pubmed: 27358453
J Eat Disord. 2020 Jan 29;8:2
pubmed: 32010444
Biol Res Nurs. 2014 Jul;16(3):327-34
pubmed: 24057221
Behav Pharmacol. 2009 Sep;20(5-6):390-9
pubmed: 19724194
Neuropsychopharmacol Hung. 2016 Mar;18(1):45-55
pubmed: 27038870
Medicine (Baltimore). 2019 Nov;98(46):e17980
pubmed: 31725664
Int J Ment Health Addict. 2018 Apr;16(2):366-376
pubmed: 29755302
Psychopharmacology (Berl). 1999 Oct;146(4):348-61
pubmed: 10550486
Psychiatry Res. 2010 Jul 30;178(2):230-5
pubmed: 20462641
Obes Rev. 2011 Sep;12(9):740-55
pubmed: 21991597
Curr Diab Rep. 2016 Sep;16(9):84
pubmed: 27473844
J Obes. 2013;2013:837989
pubmed: 23606952
Diabetes Care. 2007 Mar;30(3):744-52
pubmed: 17327354
Appetite. 2009 Apr;52(2):430-6
pubmed: 19121351
Int J Obes (Lond). 2014 Apr;38(4):507-12
pubmed: 24166064
Psychol Bull. 1995 Jan;117(1):3-20
pubmed: 7870862
J Pediatr Psychol. 2018 May 1;43(4):443-451
pubmed: 29048569
J Affect Disord. 2019 Jun 1;252:160-173
pubmed: 30986731
Nutrients. 2014 Oct 21;6(10):4552-90
pubmed: 25338274
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
J Psychosom Res. 2011 Feb;70(2):189-96
pubmed: 21262422
Arch Intern Med. 2004 Apr 26;164(8):892-6
pubmed: 15111376
Eur Eat Disord Rev. 2018 Nov;26(6):574-584
pubmed: 30159982
Appetite. 2014 Feb;73:45-50
pubmed: 24511618
J Affect Disord. 2018 Jan 15;226:346-354
pubmed: 29031185
Int J Obes (Lond). 2006 Jan;30(1):201-7
pubmed: 16231030
Eur Eat Disord Rev. 2018 Nov;26(6):657-670
pubmed: 30350446

Auteurs

Núria Mallorquí-Bagué (N)

Addictive Behaviours Unit, Department of Psychiatry, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute Sant Pau (IIB Sant Pau), Barcelona, Spain.
Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Feixa Llarga S/N, L'Hospitalet del Llobregat, 08907, Barcelona, Spain.
Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

María Lozano-Madrid (M)

Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Feixa Llarga S/N, L'Hospitalet del Llobregat, 08907, Barcelona, Spain.
Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Cristina Vintró-Alcaraz (C)

Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Feixa Llarga S/N, L'Hospitalet del Llobregat, 08907, Barcelona, Spain.
Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

Laura Forcano (L)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Integrative Pharmacology and Neurosciences Systems, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Dr. Aiguder 88, 08003, Barcelona, Spain.

Andrés Díaz-López (A)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Serra Hunter Fellow, Universitat Rovira i Virgili (URV), Reus, Spain.

Ana Galera (A)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Rebeca Fernández-Carrión (R)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Roser Granero (R)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Departament de Psicobiologia i Metodologia, Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Barcelona, Spain.

Susana Jiménez-Murcia (S)

Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Feixa Llarga S/N, L'Hospitalet del Llobregat, 08907, Barcelona, Spain.
Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.

Dolores Corella (D)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Department of Preventive Medicine, University of Valencia, Valencia, Spain.

Xavier Pintó (X)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Lipids and Vascular Risk Unit, Internal Medicine, University Hospital of Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.

Aida Cuenca-Royo (A)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Integrative Pharmacology and Neurosciences Systems, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Dr. Aiguder 88, 08003, Barcelona, Spain.

Mònica Bulló (M)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.

Jordi Salas-Salvadó (J)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Universitat Rovira i Virgili, Departament de Bioquímica i Biotecnologia, Unitat de Nutrició Humana, Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain.
Nutrition Unit, University Hospital of Sant Joan de Reus, Reus, Spain.

Rafael de la Torre (R)

Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. RTorre@imim.es.
Integrative Pharmacology and Neurosciences Systems, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Dr. Aiguder 88, 08003, Barcelona, Spain. RTorre@imim.es.
Departament de Ciències, Experimentals i de la Salut Universitat Pompeu Fabra (CEXS-UPF), Barcelona, Spain. RTorre@imim.es.

Fernando Fernández-Aranda (F)

Department of Psychiatry, University Hospital of Bellvitge-IDIBELL, Feixa Llarga S/N, L'Hospitalet del Llobregat, 08907, Barcelona, Spain. ffernandez@bellvitgehospital.cat.
Consorcio CIBER, M.P. Fisiopatología de la Obesidad y Nutrición (CIBERObn), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. ffernandez@bellvitgehospital.cat.
Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain. ffernandez@bellvitgehospital.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH